Committee Composition
| Audit | Compensation | |
|---|---|---|
|
Leslie H. Cross |
||
| James R. Glynn |
|
|
| R. Ian Molson |
|
|
| Stephen E. O'Neil |
|
|
| Audit | Compensation | |
|---|---|---|
Leslie H. Cross |
||
|
Chairman of the Board of Directors Leslie H. Cross is the non-executive Chairman of the Board of Directors. Mr. Cross is the former President and Chief Executive Officer of DJO Global, Inc. Mr. Cross continues to serve as a Director and Chairman of DJO Global. In calendar 2010, DJO Global's net sales were $966 million, with adjusted EBITDA of $262 million. DJO Global is a manufacturer and worldwide leading distributor of electrotherapy products for pain therapy and rehabilitation, clinical devices for the treatment of patients in physical therapy clinics, knee, hip and shoulder implant products, and orthopedic rehabilitation products, including rigid knee bracing, orthopedic soft goods, cold therapy systems, vascular systems and bone growth stimulation devices. Mr. Cross has held principal executive roles at DJO Global and its predecessors since 1995. From 1990 to 1994, Mr. Cross held the position of Senior Vice President of Marketing and Business Development of the Bracing & Support Systems division of Smith & Nephew. He was a Managing Director of two different divisions of Smith & Nephew from 1982 to 1990. Mr. Cross earned a diploma in medical technology from Sydney Technical College in Sydney, Australia and studied business at the University of Cape Town in Cape Town, South Africa. |
||
James R. Glynn
|
|
|
|
Director James R. Glynn has served as a Director of Alphatec Holdings since May 2007. Mr. Glynn spent much of his career in leadership positions at Invitrogen, a publicly held biotechnology company (Nasdaq:IVGN). From December 2002 to July 2003, Mr. Glynn served as the Chief Executive Officer, President and Chief Operating Officer, and from May 1998 to December 2002, he was the Executive Vice President and Chief Financial Officer of Invitrogen. Prior to Invitrogen, Mr. Glynn served as Chief Operating Officer, Chief Financial Officer and a member of the board of directors of Matrix Pharmaceutical, Inc., a pharmaceutical company focused on the treatment of cancer. Mr. Glynn is currently a Director and Chairman of the Audit Committee at American Specialty Health and a Director of eBioscience, Inc. Mr. Glynn holds a B.B.A. degree in accounting from Cleveland State University. |
||
R. Ian Molson
|
|
|
|
Director R. Ian Molson has served as a Director of Alphatec Holdings and Alphatec Spine since July 2005. Mr. Molson has served as a Director of HealthpointCapital LLC since 2004, as a Director of Sapphire Industrials Corp. since 2007 and as a Director of Cayzer Continuation PCC, an investment company, since September 2002. From June 1999 to May 2004, Mr. Molson served as Deputy Chairman for the Board of Directors, Chairman of the Executive Committee and as a member of the Audit and Financial Committee and the Human Resources and Corporate Governance Committee of Molson, Inc., one of the world's largest brewers. Between 1977 and 1997, he was employed by Credit Suisse First Boston in various capacities, including Managing Director. From 1993 to 1997, Mr. Molson served as Head of the Investment Banking Department in Europe, a position which encompassed corporate finance, corporate advisory, mergers and acquisitions businesses in Europe, Russia, Africa and the Middle East. Mr. Molson received a Bachelor of Arts degree from Harvard University. |
||
Stephen E. O'Neil
|
|
|
|
Director Stephen E. O'Neil has served as a Director of Alphatec Holdings and Alphatec Spine since July 2005. In May 1991, he founded The O'Neil Group, which provides legal and financial advice to clients primarily in the areas of mergers and acquisitions, financings and corporate strategy, where he has served as the principal since its inception. Prior to 1991, Mr. O'Neil formed a law partnership with Paul Mishkin under the name Mishkin, O'Neil for the purpose of engaging in general corporate and business law. Prior to that, he co-founded two corporations, Syntro Corporation and NovaCare, Inc., which have since become public companies. Mr. O'Neil received a Bachelor of Arts from Princeton University and a L.L.B. from Harvard Law School. |
||
